Current status and future prospects for disease modification in osteoarthritis. (19th December 2017)

• Record Type: Journal Article
• Authors: Huang, Zhengping; Ding, Changhai; Li, Tianwang; Yu, Shirley Pei-Chun
• Is Part Of: Rheumatology. Volume 57(2018)Supplement 4
• Page Start: iv108
• Page End: iv123
• Publication Date: 2017-12-19
• Subjects: osteoarthritis -- disease-modifying osteoarthritis drugs -- cartilage -- therapeutic targets -- non-pharmacological treatments; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/kex496
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: OA is a chronic, progressive and disabling joint disease, leading to a poor quality of life and an enormous social and economic burden. Current therapies for OA patients remain limited, which creates an area of huge unmet medical need. For some time, researchers have been looking for approaches that can inhibit the structural progression of OA. A variety of potential disease-modifying OA drugs have been developed, targeting cartilage, inflammatory pathways or subchondral bone. In addition, non-pharmacological therapies, including joint distraction and weight loss, draw increasing attention, with some showing disease-modifying potential. Thus we performed a comprehensive review to discuss the current status of disease-modifying therapies in OA and appraise the potentials of emerging novel agents.